Preclinical validation of a novel compound targeting p70S6 kinase in breast cancer

Breast cancer is a frequent and treatable disease. However, when recurrent, breast cancer often becomes refractory to therapy and progresses into metastatic forms that are typically incurable. Thus, understanding and targeting the critical pathways underlying breast cancer recurrence is urgently nee...

Descripción completa

Detalles Bibliográficos
Autores principales: Segatto, Ilenia, Massarut, Samuele, Boyle, Robert, Baldassarre, Gustavo, Walker, David, Belletti, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931847/
https://www.ncbi.nlm.nih.gov/pubmed/27155197
http://dx.doi.org/10.18632/aging.100954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931847/
https://www.ncbi.nlm.nih.gov/pubmed/27155197
http://dx.doi.org/10.18632/aging.100954

Ejemplares similares